Mar 01, 2018 21:02 pm UTC| Business
BOSTON, March 01, 2018 -- Ziopharm Oncology, Inc. (Nasdaq:ZIOP), a biotechnology company focused on development of next generation immunotherapies utilizing gene- and cell-based therapies to treat patients with cancer,...
Mar 01, 2018 21:01 pm UTC| Business
-- Fourth quarter 2017 EXONDYS 51® (eteplirsen) total net revenues of $57.3 million -- -- Cash and investment balance of $1.1 billion as of December 31, 2017 -- CAMBRIDGE, Mass., March 01, 2018 -- Sarepta...
Aduro Biotech Announces Fourth Quarter and Full Year 2017 Financial Results
Mar 01, 2018 21:01 pm UTC| Business
BERKELEY, Calif., March 01, 2018 -- Aduro Biotech, Inc. (NASDAQ:ADRO) today reported financial results for the year ended December 31, 2017. Net loss for the fourth quarter and year ended December 31, 2017 was $26.1...
Microchip Technology to Acquire Microsemi
Mar 01, 2018 21:01 pm UTC| Business
Significantly Expands Microchip’s solutions for Data Center, Communications, Defense and Aerospace MarketsExpected to be immediately accretive to non-GAAP earnings per shareEstimated $300 million in synergies in the third...
Microchip Technology Narrows Financial Guidance for Fourth Quarter Fiscal 2018
Mar 01, 2018 21:01 pm UTC| Business
CHANDLER, Ariz., March 01, 2018 -- (NASDAQ:MCHP) – Microchip Technology Incorporated, a leading provider of microcontroller, mixed signal, analog and Flash-IP solutions, today narrowed the range of its prior guidance...
Harvard Bioscience Reports Fourth Quarter and Year-End 2017 Results
Mar 01, 2018 21:01 pm UTC| Business
HOLLISTON, Mass., March 01, 2018 -- Harvard Bioscience, Inc. (Nasdaq:HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, reported its financial...
Tetraphase Pharmaceuticals Appoints Larry Edwards Chief Operating Officer
Mar 01, 2018 21:01 pm UTC| Business
WATERTOWN, Mass., March 01, 2018 -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant...